H3K27 乙化驱动的IGF2BP2 在MSC老化过程中发生突变,从而影响骨质分化和骨老化
Zimo Zhou1, Kai Kang2, Heran Wang1
1Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
International journal of biological sciences
|December 9, 2025
概括
介质干细胞 (MSC) 的表观遗传变化驱动骨老化. 使用CWI1-2准H3K27ac-IGF2BP2-HMGA1通路可能可以治疗骨质疏松症.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 干细胞生物学 干细胞生物学
- 老年学是指老年学的学科.
背景情况:
- 与衰老相关的骨损失与中酶体干细胞 (MSC) 衰老有关.
- 控制MSC衰老的精确表观遗传机制尚未完全理解.
研究的目的:
- 调查素H3素27乙化 (H3K27ac) 和IGF2BP2在MSC衰老中的作用.
- 探索准这种途径用于治疗与年龄相关的骨质损失的治疗干预的潜力.
主要方法:
- 在老年小鼠骨髓MSC (BM-MSCs) 中进行集成ChIP-seq和RNA-seq分析.
- 功能性研究涉及IGF2BP2淘汰和过度表达.
- 对关键IGF2BP2突变 (H65Q) 的评估及其对HMGA的影响1.1.
- 用CWI1-2进行IGF2BP2的药理抑制在试验室和老年小鼠模型中.
主要成果:
- 年龄较大的BM-MSC显示H3K27ac水平降低,IGF2BP2表达减少.
- IGF2BP2调制影响了衰老表型;它的H65Q突变通过HMGA1/p53/p21通路加速了衰老.
- 在老年小鼠中,CWI1-2治疗缓解了MSC衰老,改善了骨再生.
结论:
- H3K27ac-IGF2BP2-HMGA1轴是骨衰老的一个关键调节器.
- 用CWI1-2对IGF2BP2的药理抑制显示了与年龄相关的骨质疏松症的治疗潜力.
相关概念视频
Chromatin Modification in iPS Cells
2.1K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Histone Variants at the Centromere
4.9K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.9K
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K


